multiple myeloma Archives - BJBMS Viewpoints

September 28, 2022

Latest posts

[ September 26, 2022 ] CAV1 is a potential marker for distinguishing benign prostatic hyperplasia and prostate cancer patients Author Summary
[ September 19, 2022 ] Fusion genes can improve outcomes in B-cell precursor acute lymphoblastic leukemia patients Author Summary
[ September 13, 2022 ] The circulating isoform of the urokinase plasminogen activator receptor may aid in predicting prognosis for cancer patients Author Summary
[ September 5, 2022 ] Should older esophageal cancer patients get a different course of treatment? Author Summary
[ September 2, 2022 ] The Reviewer of the Month for September 2022: Dr Aly El-Makhzangy Reviewer of the month

NAMPT and LYST as potential therapeutic targets in multiple myeloma

August 8, 2017 0

Multiple myeloma (MM) is a type of blood cancer that affects the plasma cell. It is a rare form of cancer, accounting for 1% of all cancer diagnoses and 2% of all cancer deaths. The […]

BJBMS Viewpoints

Science in plain words

multiple myeloma

NAMPT and LYST as potential therapeutic targets in multiple myeloma

What matters the most when choosing the journal to submit your article?